KNSA
KNSA
GB00BRXB0C07
Kiniksa Pharmaceuticals Interna
Loading chart...

Financials

Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
Breakdown 2025 2024 Change %
Total Revenue 677.564.000 423.239.000
60.1%
Cost of Revenue 307.218.000 60.910.000
404.4%
Gross Profit 370.346.000 362.329.000
2.2%
293.125.000 407.945.000
28.1%
Operating Income 77.221.000 -45.616.000
269.3%
Pretax Income 88.868.000 -36.152.000
345.8%
Net Income Common Stockholders 59.005.000 -43.193.000
236.6%
-- --
--
-- --
--
ende